Journals Library


HTA - 12/01/38

Add-Aspirin Trial: A phase III double-blind placebo-controlled randomized trial assessing the addition of aspirin after standard primary therapy in early stage common solid tumours

Project title: Add-Aspirin Trial: A phase III double-blind placebo-controlled randomized trial assessing the addition of aspirin after standard primary therapy in early stage common solid tumours

Call to action: 12/01 12/01 HTA CET Open Call

Research type: Primary Research

Chief investigator: Professor Ruth LangleyORCID logoorcid.org/0000-0002-9706-016X

Contractor: University College London

Cost: £3,124,812.00

Co-investigators: Dr Alistair Ring, Dr Duncan Gilbert, Dr Fay Cafferty, Dr Michael Chapman, Dr Richard Hubner, Dr Sudeep Gupta, Dr Timothy Iveson, Mr Paul Cathcart, Professor Conjeevaram Pramesh, Professor David Cameron, Professor Howard Kynaston, Professor Janusz Jankowski, Professor Mahesh Parmar, Professor Richard Wilson.

Started: May 2014 | Status: Research in progress

ISRCTN: 74358648

Links to project documentation

The links and documents below are related to this research and are added as and when they are produced over the life of the project. The information is provided by the researchers and some may have undergone varying editorial, production and publication models, which differ to NIHR Journals Library reports. Links are to both internal (NIHR) and external websites – the NIHR is not responsible for the content of external websites.

Background & Research Questions

Why the research is being done and what is being asked

Methods

How the research is being done

Publications & Outputs

What the research produced

Outcomes & Impact

What happened as a result of the research

If you would like to receive a notification when this project is updated, please submit your email address below. This will also notify you when the Journals Library report is published.